| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |